New Medicines and Medical Devices Bill introduced in the UK

This is the first major piece of post-Brexit legislation affecting the life science industry. It was presented to Parliament earlier this month and MPs will have the opportunity to review the main principles of the legislation during its second reading on 2 March. The Bill will enable the Government to update the existing regulatory frameworks following the expiry of the Brexit transition period at the end of this year. We review this planned legislation in an article here.

Our content explained

Every piece of content we create is correct on the date it’s published but please don’t rely on it as legal advice. If you’d like to speak to us about your own legal requirements, please contact one of our expert lawyers.

Posted by


Mills & Reeve Sites navigation
A tabbed collection of Mills & Reeve sites.
My Mills & Reeve navigation
Subscribe to, or manage your My Mills & Reeve account.
My M&R


Register for My M&R to stay up-to-date with legal news and events, create brochures and bookmark pages.

Existing clients

Log in to your client extranet for free matter information, know-how and documents.


Mills & Reeve system for employees.